Daniel Resnic is the inventor of ORIGAMI Condoms™. He is the founder of his product design firm, Strata Various Product Design, based in Los Angeles, CA. He is uniquely qualified with a vision and commitment to product design and clinical research. Resnic has served as Principal Investigator for NIH-funded clinical research projects since 2004: the ORIGAMI Male Condom™, a non-latex, non-rolled silicone male condom, in collaboration with the California Family with Health Council, Los Angeles; the ORIGAMI Female Condom™, in collaboration with the Women’s Global Health Imperative at RTI, International., San Francisco; and the ORIGAMI R.A.I. Condom™ in collaboration with The Fenway Institute, Boston.
The primary company goal is to advance the new condoms through fabrication, pre-clinical testing, and into their clinical trials. The devices will be submitted to the FDA and the WHO for pre-market review in 2014. Mr. Resnic will oversee the ORIGAMI’s path to commercial manufacturing and marketing. The company is pursuing the potential for licensing with global partnerships.
Mr. Resnic studied packaging and product design in the early 1970’s at the Art Center College of Design in Californiax. After his studies, he founded several successful design and publishing businesses. In 2001, after realizing how consumer dissatisfaction had marked the history of the rolled, latex condom, designed in 1918, Mr. Resnic directed his company’s attention to product design with a specific focus on condoms. He researched the characteristics that have prevented condoms from being used as extensively and consistently as needed to curtail the current HIV epidemic. After a year long investigation, he identified several key areas where design solutions could have a marked effect on consumer satisfaction:
- Creating a barrier that does not diminish sensitivity
- Improving fit and reducing constriction
- Making the condom easier and quicker to don (minimize interruption of sexual activity)
- Reducing slippage by designing a means of securing the condom
- Reducing breakage by searching for a more durable alternative to latex and plastic
- Finding an alternative material that is acceptable to consumers with latex allergy (2% of population)
The new condoms are designed to meet or exceed acceptable FDA and WHO performance standards. Mr. Resnic was awarded a U.S. patent in March 2012, and approval of international patents for the novel devices are anticipated.